These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

453 related items for PubMed ID: 22900951

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Frovatriptan for the acute treatment of migraine: a dose-finding study.
    Goldstein J, Keywood C, 251/96/14 Study Group.
    Headache; 2002 Jan; 42(1):41-8. PubMed ID: 12005274
    [Abstract] [Full Text] [Related]

  • 24. Efficacy of frovatriptan and other triptans in the treatment of acute migraine of normal weight and obese subjects: a review of randomized studies.
    Saracco MG, Allais G, Tullo V, Zava D, Pezzola D, Reggiardo G, Omboni S, Benedetto C, Bussone G, Aguggia M.
    Neurol Sci; 2014 May; 35 Suppl 1():115-9. PubMed ID: 24867847
    [Abstract] [Full Text] [Related]

  • 25. Eletriptan: a review of its use in the acute treatment of migraine.
    McCormack PL, Keating GM.
    Drugs; 2006 May; 66(8):1129-49. PubMed ID: 16789799
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Dose range-finding studies with frovatriptan in the acute treatment of migraine.
    Rapoport A, Ryan R, Goldstein J, Keywood C.
    Headache; 2002 Apr; 42 Suppl 2():S74-83. PubMed ID: 12028323
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Meta-analysis examining the efficacy and safety of almotriptan in the acute treatment of migraine.
    Chen LC, Ashcroft DM.
    Headache; 2007 Sep; 47(8):1169-77. PubMed ID: 17883521
    [Abstract] [Full Text] [Related]

  • 30. Triptans for the management of migraine.
    Johnston MM, Rapoport AM.
    Drugs; 2010 Aug 20; 70(12):1505-18. PubMed ID: 20687618
    [Abstract] [Full Text] [Related]

  • 31. Newer formulations of the triptans: advances in migraine management.
    Gladstone JP, Gawel M.
    Drugs; 2003 Aug 20; 63(21):2285-305. PubMed ID: 14524731
    [Abstract] [Full Text] [Related]

  • 32. Pharmacokinetics of two 6-day frovatriptan dosing regimens used for the short-term prevention of menstrual migraine: A phase I, randomized, double-blind, placebo-controlled, two-period crossover, single-centre study in healthy female volunteers.
    Wade A, Pawsey S, Whale H, Boyce M, Warrington S.
    Clin Drug Investig; 2009 Aug 20; 29(5):325-37. PubMed ID: 19366274
    [Abstract] [Full Text] [Related]

  • 33. Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.
    Savi L, Omboni S, Lisotto C, Zanchin G, Ferrari MD, Zava D, Pinessi L.
    J Headache Pain; 2011 Dec 20; 12(6):609-15. PubMed ID: 21842274
    [Abstract] [Full Text] [Related]

  • 34. Efficacy of frovatriptan as compared to other triptans in migraine with aura.
    Evers S, Savi L, Omboni S, Lisotto C, Zanchin G, Pinessi L.
    J Headache Pain; 2015 Dec 20; 16():514. PubMed ID: 25916333
    [Abstract] [Full Text] [Related]

  • 35. Comparison of frovatriptan plus dexketoprofen (25 mg or 37.5 mg) with frovatriptan alone in the treatment of migraine attacks with or without aura: a randomized study.
    Tullo V, Valguarnera F, Barbanti P, Cortelli P, Sette G, Allais G, d'Onofrio F, Curone M, Zava D, Pezzola D, Benedetto C, Frediani F, Bussone G.
    Cephalalgia; 2014 May 20; 34(6):434-45. PubMed ID: 24363238
    [Abstract] [Full Text] [Related]

  • 36. Spotlight on rizatriptan in migraine.
    Wellington K, Jarvis B.
    CNS Drugs; 2002 May 20; 16(10):715-20. PubMed ID: 12269863
    [Abstract] [Full Text] [Related]

  • 37. Tolerability and consistency of effect of zolmitriptan nasal spray in a long-term migraine treatment trial.
    Dowson AJ, Charlesworth BR, Purdy A, Becker WJ, Boes-Hansen S, Färkkilä M.
    CNS Drugs; 2003 May 20; 17(11):839-51. PubMed ID: 12921494
    [Abstract] [Full Text] [Related]

  • 38. Speed of onset, efficacy and tolerability of zolmitriptan nasal spray in the acute treatment of migraine: a randomised, double-blind, placebo-controlled study.
    Dodick D, Brandes J, Elkind A, Mathew N, Rodichok L.
    CNS Drugs; 2005 May 20; 19(2):125-36. PubMed ID: 15697326
    [Abstract] [Full Text] [Related]

  • 39. Early (≤ 1-h) vs. late (>1-h) administration of frovatriptan plus dexketoprofen combination vs. frovatriptan monotherapy in the acute treatment of migraine attacks with or without aura: a post hoc analysis of a double-blind, randomized, parallel group study.
    Allais G, Bussone G, Tullo V, Cortelli P, Valguarnera F, Barbanti P, Sette G, Frediani F, D'Arrigo G, d'Onofrio F, Comi G, Curone M, Colombo B, Omboni S, Benedetto C.
    Neurol Sci; 2015 May 20; 36 Suppl 1():161-7. PubMed ID: 26017535
    [Abstract] [Full Text] [Related]

  • 40. Scheduled short-term prevention with frovatriptan for migraine occurring exclusively in association with menstruation.
    Silberstein SD, Berner T, Tobin J, Xiang Q, Campbell JC.
    Headache; 2009 Oct 20; 49(9):1283-97. PubMed ID: 19751371
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 23.